Intestine-Derived Matrix Metalloproteinase-8 Is a Critical Mediator of Polymicrobial Peritonitis

Critical Care Medicine

Volumn 44, Issue 4, 2016, Pages e200-e206

  Atkinson, Sarah J ^a,b   Nolan, Meghan ^a,b   Klingbeil, Lindsey ^a,b   Harmon, Kelli ^a   Lahni, Patrick ^a   Zingarelli, Basilia ^a,b   Wong, Hector R ^a,b  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

intestinal injury; matrix metalloproteinase 8; peritonitis; sepsis

Indexed keywords

ALPHA CHEMOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUTROPHIL COLLAGENASE; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME BLOOD LEVEL; GENOTYPE; GRAFT RECIPIENT; INTESTINE TRANSPLANTATION; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SURVIVAL; WILD TYPE; ANIMAL; C57BL MOUSE; CECUM; DISEASE MODEL; INTESTINE; LIGATION; MALE; METABOLISM; MICROBIOLOGY; PUNCTURE; SHOCK, SEPTIC;

ANIMALS; CECUM; DISEASE MODELS, ANIMAL; INTESTINES; LIGATION; MALE; MATRIX METALLOPROTEINASE 8; MICE; MICE, INBRED C57BL; PERITONITIS; PUNCTURES; SEPSIS; SHOCK, SEPTIC;

EID: 84945156653     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001374     Document Type: Article

References (29)

1. Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK, Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 2012 40 754 761
2. Solan PD, Dunsmore KE, Denenberg AG, A novel role for matrix metalloproteinase-8 in sepsis. Crit Care Med 2012 40 379 387
3. Fink MP, Matrix metalloproteinase-8 as a potential drug target for the therapy of sepsis. Crit Care Med 2012 40 655 656
4. Quintero PA, Knolle MD, Cala LF, Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice. J Immunol 2010 184 1575 1588
5. Tester AM, Cox JH, Connor AR, LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PLoS One 2007 2 e312
6. Van Lint P, Libert C, Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 2007 82 1375 1381
7. Zingarelli B, Piraino G, Hake PW, Peroxisome proliferator-activated receptor {delta} regulates inflammation via NF-{kappa}B signaling in polymicrobial sepsis. Am J Pathol 2010 177 1834 1847
8. Wynn JL, Scumpia PO, Delano MJ, Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 2007 28 675 683
9. Wong HR, Genome-wide expression profiling in pediatric septic shock. Pediatr Res 2013 73 564 569
10. Cvijanovich N, Shanley TP, Lin R, Genomics of Pediatric SIRS/Septic Shock Investigators Validating the genomic signature of pediatric septic shock. Physiol Genomics 2008 34 127 134
11. Shanley TP, Cvijanovich N, Lin R, Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 2007 13 495 508
12. Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005 6 2 8
13. Wong HR, Salisbury S, Xiao Q, The pediatric sepsis biomarker risk model. Crit Care 2012 16 R174
14. Leligdowicz A, Dodek PM, Norena M, Co-operative Antimicrobial Therapy of Septic Shock Database Research Group Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med 2014 189 1204 1213
15. Ayala A, Song GY, Chung CS, Immune depression in polymicrobial sepsis: The role of necrotic (injured) tissue and endotoxin. Crit Care Med 2000 28 2949 2955
16. Van Lint P, Wielockx B, Puimège L, Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis. J Immunol 2005 175 7642 7649
17. Folgueras AR, Fueyo A, García-Suárez O, Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice. J Biol Chem 2008 283 9465 9474
18. Lee EJ, Han JE, Woo MS, Matrix metalloproteinase-8 plays a pivotal role in neuroinflammation by modulating TNF-α activation. J Immunol 2014 193 2384 2393
19. Owen CA, Hu Z, Lopez-Otin C, Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J Immunol 2004 172 7791 7803
20. Craig VJ, Quintero PA, Fyfe SE, Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury. J Immunol 2013 190 4283 4296
21. González-López A, Aguirre A, López-Alonso I, MMP-8 deficiency increases TLR/RAGE ligands S100A8 and S100A9 and exacerbates lung inflammation during endotoxemia. PLoS One 2012 7 e39940
22. Seok J, Warren HS, Cuenca AG, Inflammation and Host Response to Injury, Large Scale Collaborative Research Program Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013 110 3507 3512
23. Osuchowski MF, Remick DG, Lederer JA, Abandon the mouse research ship? Not just yet! Shock 2014 41 463 475
24. Gutiérrez-Fernández A, Inada M, Balbín M, Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J 2007 21 2580 2591
25. Rella JM, Jilma B, Fabry A, MMP-8 genotypes influence the inflammatory response in human endotoxemia. Inflammation 2014 37 451 456
26. Fingleton B, MMPs as therapeutic targets-still a viable option? Semin Cell Dev Biol 2008 19 61 68
27. Jacobsen JA, Major Jourden JL, Miller MT, To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition. Biochim Biophys Acta 2010 1803 72 94
28. Vandenbroucke RE, Libert C, Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov 2014 13 904 927
29. Whittaker M, Floyd CD, Brown P, Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev 1999 99 2735 2776